CerTest Biotec

CerTest Biotec is an established, independent IVD company with a diversified portfolio spanning rapid immunochromatographic tests, RT-PCR kits, NGS solutions, and raw materials for diagnostics. The company demonstrates a clear growth trajectory from its core diagnostics business into adjacent areas like RNA vaccines and bioinformatics, indicating a strategic expansion of its technological platform. With a workforce of over 50 employees and a global distribution network, CerTest leverages its expertise in molecular and immunoassay diagnostics to address infectious disease threats, supported by a strong emphasis on quality, innovation, and customer orientation.

Multi-platform diagnostics including immunochromatography, turbidimetry, Real-Time PCR (RT-PCR), Next-Generation Sequencing (NGS) with bioinformatics, and Chemiluminescence Immunoassay (CLIA). Also developing an RNA vaccine platform for infectious diseases and cancer immunotherapy.

In diagnostics, CerTest competes with global IVD giants (e.g., Roche, Abbott, bioMérieux) and numerous specialized players in PCR and rapid tests. In NGS, it competes with Illumina, Thermo Fisher, and other library prep providers. Its vaccine venture would place it against large pharmaceutical companies and well-funded biotechs in the mRNA space, making differentiation and focus critical.